Healthcare
Capital Markets
August 2022
Medical office investment trends point to another record year in 2022
Transactions larger than $2.5 million
Source: JLL Research, Real Capital Analytics
Key points:
  • Medical office sales soared in the first half 2022 at $9.2 billion, drafting off of strong investor interest in 2021.  First half 2022 sales were nearly half of 2021’s record volume of $19.6 billion, an astonishing feat and a clear indicator of the swell of investment capital available to deploy.  Regardless of macro market disruption that started in the spring that is slowing deal velocity, JLL believes that 2022 will be another record year, exceeding even 2021.  The $11 billion merger of Healthcare Realty Trust and Healthcare Trust of America in July 2022 helps guarantee this outcome.  Importantly, however, healthcare investments have been less affected by market conditions, for a variety of reasons, resulting in a later and shallower impact on pricing and appetite than other property sectors.
  • The year-over-year comparison of first half sales is easily explained by the accelerated pace of investment activity which occurred over the course of 2021.  Notably,  the momentum of major portfolio transactions (>$300 million) exceeded all historical levels and drove the total sales activity in 2021.  JLL previously reported a record $7.7 billion in portfolio transactions in 2021, nearly half of which featured new entrants seeking to deploy substantial equity checks in an efficient manner.  The timing of first half 2022 volume benefited from commitments made in 2021. 
  • However, medical office interest and pricing defied gravity throughout the spring and two to three months longer than other hot property classes.  This phenomenon was due to a combination of unparalleled property sector fundamentals, largely unimpacted by economic and market volatility, and continual support and new loan commitments from commercial banks, which have been the lender of choice in healthcare.  While medical office has not been unaffected by pricing shifts, JLL posits that the pricing adjustments are much less than other preferred asset classes, and new commitments to property acquisitions are providing the needed pricing discovery to bolster investor confidence in the sector.   
  • With several large portfolios in stages of closing and the market re-stabilizing, JLL is confident about continued strong investor interest in the healthcare property class.  The growth in demand driven healthcare needs combined with the movement to outpatient care provides ample support for healthy investor appetite for medical office.

JLL is proud to announce $2.2 billion in 2022 year-to-date closed capital markets transactions for medical office and hospital sales, financing and equity placement

Recent Activity
New Listing - Investment Sale
FHE Health Behavioral Portfolio
105,333 s.f.
Deerfield Beach, FL
New Listing - Investment Sale
Utah On-Campus MOB Portfolio
85,056 s.f.
Salt Lake City Metro, UT
New Listing - Investment Sale
Baltimore VA Clinic
68,121 s.f.
Baltimore, MD
New Listing - Debt & Equity Placement
AM Behavioral of Oregon 
52,523 s.f.
Oregon, OH
Closed - Investment Sale
.
Shady Grove Professional Center
103,249 s.f.
Rockville, MD
Closed - Investment Sale
.
Prosperity Medical Plaza
22,515 s.f.
Charlotte, NC
 
Closed - Investment Sale
Hopebridge – South Bend
12,000 s.f.
South Bend, IN
Closed - Investment Sale
ImageCare Radiology SLB – Fair Lawn
5,300 s.f.
Fair Lawn, NJ
Want to receive more deal opportunities? Register for the JLL Investor Center, our portal offering secure and easy access to our global inventory of investment opportunities. 

From any device, anywhere in the world, you can search and view listings, receive invitations to private listings, and edit your preferences so you only receive opportunities that meet your specific criteria. Register for the Investor Center here>
Healthcare Capital Markets Contacts
Healthcare investment sales & advisory contacts
East
 
Mindy Berman
Senior Managing Director
+1 617 316 6539
Ted Flagg
Senior Managing Director
+1 917 215 7036
Brannan Knott
Managing Director
+1 617 316 6508
Central
 
Brian Bacharach
Senior Managing Director
+1 214 438 6462
West
 
Evan Kovac
Senior Managing Director
+1 206 336 5439
Andrew Milne
Senior Managing Director
+1 858 812 2370
Matt DiCesare
Director
+1 310 407 2149
 
Healthcare debt advisory contacts
East
 
Anthony Sardo
Director
+1 617 531 4198
Central
 
Timothy Joyce
Managing Director
+1 312 528 3652
West
 
John Chun
Managing Director
+1 949 798 4108